New position: ANIP Ani Pharmaceuticals Inc
0.0% of the reported portfolio, $493K.
46 of the 46 investors we follow have filed their 13F for Q1 2026 (the latest on May 15, 2026). A new position was not in their previous 13F. A sold-out one is gone from this one. 13F shows long positions in US stocks, up to 45 days after the quarter ends.
The bar is the number of new positions; the figure shows new / sold out. The twelve investors with the most changes.
330 new positions in Q1 2026, largest share of the portfolio first.
0.0% of the reported portfolio, $493K.
0.0% of the reported portfolio, $182K.
0.0% of the reported portfolio, $537K.
0.0% of the reported portfolio, $568K.
0.0% of the reported portfolio, $515K.
0.0% of the reported portfolio, $157K.
0.0% of the reported portfolio, $407K.
0.0% of the reported portfolio, $664K.
0.0% of the reported portfolio, $372K.
0.0% of the reported portfolio, $209K.
0.0% of the reported portfolio, $236K.
0.0% of the reported portfolio, $390K.
0.0% of the reported portfolio, $330K.
0.0% of the reported portfolio, $375K.
0.0% of the reported portfolio, $358K.
0.0% of the reported portfolio, $469K.
0.0% of the reported portfolio, $82K.
0.0% of the reported portfolio, $346K.
0.0% of the reported portfolio, $316K.
0.0% of the reported portfolio, $477K.
0.0% of the reported portfolio, $351K.
0.0% of the reported portfolio, $349K.
0.0% of the reported portfolio, $380K.
0.0% of the reported portfolio, $373K.
0.0% of the reported portfolio, $149K.
0.0% of the reported portfolio, $236K.
0.0% of the reported portfolio, $3.2M.
0.0% of the reported portfolio, $214K.
0.0% of the reported portfolio, $960K.
0.0% of the reported portfolio, $2.1M.
0.0% of the reported portfolio, $580K.
0.0% of the reported portfolio, $1.9M.
0.0% of the reported portfolio, $2.2M.
0.0% of the reported portfolio, $376K.
0.0% of the reported portfolio, $1.1M.
0.0% of the reported portfolio, $886K.
0.0% of the reported portfolio, $996K.
0.0% of the reported portfolio, $449K.
0.0% of the reported portfolio, $1.9M.